Orthopediatrics Corp - Asset Resilience Ratio
Orthopediatrics Corp (KIDS) has an Asset Resilience Ratio of 7.29% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Orthopediatrics Corp's Asset Resilience Ratio has changed over time. Check KIDS PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Orthopediatrics Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Orthopediatrics Corp market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $36.62 Million | 7.29% |
| Total Liquid Assets | $36.62 Million | 7.29% |
Asset Resilience Insights
- Limited Liquidity: Orthopediatrics Corp maintains only 7.29% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Orthopediatrics Corp Industry Peers by Asset Resilience Ratio
Compare Orthopediatrics Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Beijing Succeeder Technology Inc
SHG:688338 |
Medical Devices | 28.27% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 34.47% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
Annual Asset Resilience Ratio for Orthopediatrics Corp (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Orthopediatrics Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 8.12% | $41.30 Million | $508.63 Million | +2.83pp |
| 2024-12-31 | 5.29% | $25.01 Million | $473.21 Million | -5.94pp |
| 2023-12-31 | 11.23% | $49.25 Million | $438.75 Million | -14.33pp |
| 2022-12-31 | 25.55% | $109.30 Million | $427.73 Million | +10.67pp |
| 2021-12-31 | 14.88% | $45.90 Million | $308.40 Million | -2.09pp |
| 2020-12-31 | 16.98% | $55.14 Million | $324.83 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $82.30 Million | -- |
About Orthopediatrics Corp
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sp… Read more